Leading Researcher Optimistic about New Treatments for MsSeveral new medicines for treating multiple sclerosis may become widely available in the next three years, a top medical researcher said here Wednesday.Schieszer, John
Chapter 36 – New treatments for multiple sclerosisChapter 36 – New treatments for multiple sclerosisThis chapter presents an overview of new treatments for multiple sclerosis (MS). MS is a disease of the central nervous system (CNS) in which the demyelination and synthesis of immunoglobu...
Influenza has a long history of causing morbidity and mortality in the human population through routine seasonal spread and global pandemics. The high mutation rate of the RNA genome of the influenza virus, combined with assortment of its multiple genomi
Amy Brian, PharmD, CGP, CPP Traditionally, insulin has beenavailable only as a more-thanonce-daily subcutaneous injectionfor patients. Insulin glargine(Lantus) is a synthetic insulin developedthat simulates 24-hour basalinsulin production, allowing certainpatients with type 2 diabetes to reducetheir ...
With newer agents approved for patients with chronic lymphocytic leukemia, physicians are now challenged with how best to utilize them.
16,17 Future studies should evaluate whether evidence for type 2 diabetes persists beyond the time period that could be affected by treatments. Data regarding postacute symptoms and conditions in children are scarce. Studies have highlighted prolonged fatigue, headaches, sleep disturbances, cognitive ...
Jose Rey, MS, PharmD, BCPP So, what gaps exist. I would say the important gaps are that we haven't cured the disorder of schizophrenia. Our treatments are, I want to say, sometimes that they've hit a wall, we have limited efficacy. Even when we're trying to treat problems like ...
Among patients undergoing mechanical ventilation and receiving hydroxychloroquine + azithromycin, hydroxychloroquine alone, or azithromycin alone, 49.6% were ventilated before or concurrent with starting these treatments. Primary Outcome Overall in-hospital mortality was 20.3% (95% CI, 18.2%-22.4%)....
For computational efficiency, global models use simplified SOA treatments, which often do not capture the dynamics of SOA formation. Here we test more complex SOA treatments within the global Energy Exascale Earth System Model (E3SM) to investigate how simulated SOA spatial distributions respond to ...
My treatments and medications are scattered here and there. I have a few items in the little cubby above the sink in the camper. I store some things in a basket next to my bed for night time use. I also have a tin that sits at the table with various strains of cannabis flower and...